Remove Definition Remove Labelling Remove Packaging
article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

This concerns the quantity of the medicinal product in the packaging, ie, the increase or decrease in the number of units of the product in the outer packaging according to local demands and its labelling, including the leaflet, which should be in the language of the country into which the product is imported.

article thumbnail

FDA Issues Long-Awaited QMSR Final Rule

FDA Law Blog: Biosimilars

Both ISO 13485 and ISO 9000 contain terms and definitions that are referenced within Part 820. FDA further retained some definitions in the QSMR. FDA further retained some definitions in the QSMR. Certain definitions are also removed from § 820.3, Revised § 820.3 Subpart B reserves §§ 820.20 – 820.30, 820.40.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

November 2023 Newsletter

Safe Biologics

The difference between the definitions of interchangeability in Europe and in the U.S. The guidance removed the interchangeability statement from the product label/package insert of interchangeable biosimilars. state law, only interchangeable biosimilars may be substituted by a pharmacist without contacting the prescriber.

article thumbnail

Pet Food Institute Proposes Modernization of Pet Food and Treats Regulation

FDA Law Blog: Biosimilars

The Federal Food, Drug, and Cosmetic Act (FDC Act) requires that all animal foods, like human foods, be safe to eat, produced under sanitary conditions, contain no harmful substances, and be truthfully labeled. AAFCO also publishes model regulations, including model pet food labeling regulations which states may adopt.

article thumbnail

What is a natural health product? Health Canada’s findings upheld by Federal Courts

Pharma in Brief

The statutory definition In Canada, natural health products are defined as drugs under the Food and Drugs Act but are generally not subject to the Food and Drug Regulations. These distinctions are important as they determine the regulatory burden required to market a product in Canada. In its August 16, 2023 decision in Le-Vel Brands, LLC v.

article thumbnail

Drug advertising: Updated guidance from Health Canada on the distinction between advertising and other activities for health products

Pharma in Brief

This long-awaited update broadens the definition of advertising and promotional messages and activities, and requires a contextual analysis to determine whether a particular message or activity is promotional or non-promotional in nature. Definition of “general public”.

article thumbnail

GMP rules to keep pharmaceutical warehouse in perfect condition

GMPSOP

A pharmaceutical warehouse is responsible for receiving, storing, and releasing incoming goods (including labeling and packaging) and distributing finished products. – GDP and GWP are each special parts of GMP. – GDP and GWP each have their legal definitions and regulations.